Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Notes Payables (2023 - 2024)

Biofrontera (BFRI) has 2 years of Notes Payables data on record, last reported at $296000.0 in Q2 2024.

  • For Q2 2024, Notes Payables changed N/A year-over-year to $296000.0; the TTM value through Jun 2024 reached $296000.0, changed N/A, while the annual FY2023 figure was $3.9 million, N/A changed from the prior year.
  • Notes Payables reached $296000.0 in Q2 2024 per BFRI's latest filing, down from $2.4 million in the prior quarter.
  • Across five years, Notes Payables topped out at $3.9 million in Q4 2023 and bottomed at $296000.0 in Q2 2024.